Reuters logo
9 个月前
BRIEF-Allergan receives FDA clearance for a new surgical treatment for refractory glaucoma
2016年11月22日 / 下午12点57分 / 9 个月前

BRIEF-Allergan receives FDA clearance for a new surgical treatment for refractory glaucoma

Nov 22 (Reuters) - Allergan Plc :

* Allergan receives FDA clearance for the xen gel stent, a new surgical treatment for refractory glaucoma

* Allergan Plc - Allergan plans to launch xen in U.S. In early 2017

* Allergan Plc - Allergan plans to launch xen glaucoma treatment system in U.S. in early 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below